27621870|t|Correlation of cardiopulmonary exercise testing parameters with quality of life in stable COPD patients
27621870|a|The precise head to head relationships between Cardio-pulmonary exercise testing (CPET) parameters and patients ' daily symptoms / activities and the disease social / emotional impact are less well defined. In this study, the correlation of COPD daily symptoms and quality of life [assessed by St. George's Respiratory Questionnaire (SGRQ)] and COPD severity index (BODE-index) with CPET parameters were investigated. Symptom -limited CPET was performed in 37 consecutive COPD (GOLD I-III) subjects during non- exacerbation phase. The SGRQ was also completed by each patient. SGRQ-score correlated negatively with FEV1 (r=-0.49, P<0.01), predicted maximal work-rate (%WR-max) (r=-0.44, P<0.01), V'O2 / WR (r=-0.52, P<0.01) and breathing reserve (r=-0.50, P<0.01). However it did not correlate with Peak-V'O2 % predicted (r=-0.27, P=0.10). In 20 (54.1%) subjects in which leg fatigue was the main cause for stopping the test, Peak-V'O2, %WR-max, HR-Reserve and Breathing reserve were higher (P=0.04, <0.01, 0.04 and <0.01 respectively) than the others. There was also a significant correlation between BODE-index and ∆VO2 / ∆WR (r=-0.64, P<0.001) and breathing-reserve (r=-0.38, P=0.018). The observed relationships between CPET parameter and daily subjective complaints in COPD were not strong. Those who discontinued the CPET because of leg fatigue were in the earlier stages of COPD. Significant negative correlation between ∆VO2 / ∆WR and BODE-index suggests that along with COPD progression, regardless of negative past history, other comorbidities such as cardiac / musculoskeletal problems should be sought.
27621870	0	11	Correlation	T080	C1707520
27621870	15	47	cardiopulmonary exercise testing	T060	C2959886
27621870	48	58	parameters	T077	C0549193
27621870	64	79	quality of life	T078	C0034380
27621870	83	89	stable	T033	C0677946
27621870	90	94	COPD	T047	C0024117
27621870	95	103	patients	T101	C0030705
27621870	129	142	relationships	T080	C0439849
27621870	151	184	Cardio-pulmonary exercise testing	T060	C2959886
27621870	186	190	CPET	T060	C2959886
27621870	192	202	parameters	T077	C0549193
27621870	207	215	patients	T101	C0030705
27621870	218	232	daily symptoms	T033	C0436354
27621870	235	245	activities	T056	C0871707
27621870	254	261	disease	T047	C0012634
27621870	262	268	social	T080	C0162468
27621870	271	287	emotional impact	T201	C1514593
27621870	330	341	correlation	T080	C1707520
27621870	345	349	COPD	T047	C0024117
27621870	350	364	daily symptoms	T033	C0436354
27621870	369	384	quality of life	T078	C0034380
27621870	398	436	St. George's Respiratory Questionnaire	T170	C0451500
27621870	438	442	SGRQ	T170	C0451500
27621870	449	453	COPD	T047	C0024117
27621870	454	468	severity index	T170	C4053940
27621870	470	480	BODE-index	T170	C4053940
27621870	487	491	CPET	T060	C2959886
27621870	492	502	parameters	T077	C0549193
27621870	522	529	Symptom	T184	C1457887
27621870	539	543	CPET	T060	C2959886
27621870	564	575	consecutive	T080	C1707491
27621870	576	580	COPD	T047	C0024117
27621870	582	592	GOLD I-III	T060	C0699749
27621870	615	627	exacerbation	T047	C0740304
27621870	628	633	phase	T079	C0205390
27621870	639	643	SGRQ	T170	C0451500
27621870	671	678	patient	T101	C0030705
27621870	680	690	SGRQ-score	T201	C3472502
27621870	691	701	correlated	T080	C1707520
27621870	702	712	negatively	T033	C0205160
27621870	718	722	FEV1	T060	C0849974
27621870	742	751	predicted	T078	C0681842
27621870	752	769	maximal work-rate	T033	C0744679
27621870	771	778	%WR-max	T033	C0744679
27621870	799	803	V'O2	T033	C0429627
27621870	806	808	WR	T201	C0018810
27621870	831	848	breathing reserve	T081	C0392762
27621870	879	896	did not correlate	T033	C0243095
27621870	902	911	Peak-V'O2	T033	C0429693
27621870	975	1027	leg fatigue was the main cause for stopping the test	T033	C2036296
27621870	1029	1038	Peak-V'O2	T033	C0429693
27621870	1040	1047	%WR-max	T033	C0744679
27621870	1049	1059	HR-Reserve	T081	C0392762
27621870	1064	1081	Breathing reserve	T081	C0392762
27621870	1173	1184	significant	T081	C0237881
27621870	1185	1196	correlation	T080	C1707520
27621870	1205	1215	BODE-index	T170	C4053940
27621870	1220	1224	∆VO2	T033	C0429627
27621870	1227	1230	∆WR	T201	C0018810
27621870	1254	1271	breathing-reserve	T081	C0392762
27621870	1305	1318	relationships	T080	C0439849
27621870	1327	1331	CPET	T060	C2959886
27621870	1332	1341	parameter	T077	C0549193
27621870	1346	1351	daily	T079	C0332173
27621870	1352	1373	subjective complaints	T041	C2936631
27621870	1377	1381	COPD	T047	C0024117
27621870	1426	1430	CPET	T060	C2959886
27621870	1431	1453	because of leg fatigue	T033	C2036296
27621870	1466	1480	earlier stages	T079	C2363430
27621870	1484	1488	COPD	T047	C0024117
27621870	1502	1510	negative	T033	C0205160
27621870	1511	1522	correlation	T080	C1707520
27621870	1531	1535	∆VO2	T033	C0429627
27621870	1538	1541	∆WR	T201	C0018810
27621870	1546	1556	BODE-index	T170	C4053940
27621870	1582	1586	COPD	T047	C0024117
27621870	1587	1598	progression	T046	C0242656
27621870	1614	1635	negative past history	T033	C3699386
27621870	1643	1656	comorbidities	T078	C0009488
27621870	1665	1672	cardiac	T033	C0262402
27621870	1675	1699	musculoskeletal problems	T033	C0026859